On March 24, 2026, Karyopharm Therapeutics Inc. agreed to sell 1,030,354 shares at $6.785 each and pre-funded warrants in a deal expected to raise around $30 million, closing on March 26, 2026. Additionally, the company raised approximately $19.8 million through an Open Market Sale Agreement, resulting in a total of over 22 million shares outstanding.